Pascal Biosciences Inc.
Pascal Biosciences Inc. (formerly bioMmune technologies Inc.) was founded in 2013 in Vancouver, Canada based on discovery research at The University of British Columbia (UBC). To realize clinical benefit from the fruits of the ongoing basic discovery research at UBC, Pascal has recently established an R&D subsidiary in Seattle, WA. This facility is led by biotech veterans with an average of 25 years of drug discovery and development experience. Our dedicated team is driven to discover novel therapeutics to bolster the immune system to fight cancer, autoimmunity, and infectious disease.
The company’s stock is publicly traded on the TSX: Venture Exchange under the symbol "PAS".